Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Crescent Biopharma (CBIO) Asset Utilization Ratio (2016 - 2026)

Crescent Biopharma (CBIO) has disclosed Asset Utilization Ratio for 10 consecutive years, with 0.0 as the latest value for Q1 2026.

  • For Q1 2026, Asset Utilization Ratio changed N/A year-over-year to 0.0; the TTM value through Mar 2026 reached 0.0, changed N/A, while the annual FY2023 figure was 0.0, 79.94% down from the prior year.
  • Asset Utilization Ratio hit 0.0 in Q1 2026 for Crescent Biopharma, up from 0.01 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.0 in Q2 2022 and bottomed at 0.01 in Q2 2025.
  • Average Asset Utilization Ratio over 4 years is 0.0, with a median of 0.0 recorded in 2022.
  • Year-over-year, Asset Utilization Ratio crashed 92.49% in 2022 and then increased 4.69% in 2023.
  • Crescent Biopharma's Asset Utilization Ratio stood at 0.0 in 2022, then dropped by 10.73% to 0.0 in 2023, then crashed by 556.27% to 0.01 in 2025, then soared by 97.27% to 0.0 in 2026.
  • According to Business Quant data, Asset Utilization Ratio over the past three periods came in at 0.0, 0.01, and 0.01 for Q1 2026, Q4 2025, and Q3 2025 respectively.